Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2022

MissionIRNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) (FSE: 80W) Releases Letter to Stockholders

Posted on April 6, 2022 by MissionIR

Save Foods (NASDAQ: SVFD) (FSE: 80W), an agri-food tech company specializing in eco crop protection that helps reduce food waste and ensure food safety, published a letter to its stockholders from CEO David Palach. “We achieved multiple significant milestones in … Continue reading →

Posted in Save Foods Inc. SVFD | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Participate in Upcoming Benzinga Psychedelics Capital Conference

Posted on April 6, 2022 by MissionIR

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be represented at the Benzinga Psychedelics Capital Conference. The premier event is scheduled for April 19, 2022, and will be held in Miami Beach, Florida. … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) Finalized ‘Momentous’ Transact Europe Acquisition

Posted on April 6, 2022 by MissionIR

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has completed its acquisition of Transact Europe Holdings (“TEU”). According to the company, the $28 million purchase price was substantiated by the value of Transact Europe’s business volume, strategic licenses, … Continue reading →

Posted in GreenBox POS. GBOX | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Multiple Strong Market Paths

Posted on April 6, 2022 by MissionIR

Lexaria is a global innovator that has developed the patented DehydraTECH(TM) technology that improves bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“APIs”) The company strategically partners with third-party organizations seeking to explore formulation opportunities with their … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

Posted on April 6, 2022 by MissionIR

InMed Pharmaceuticals is a Canadian clinical-stage drug development company focused on the development of rare cannabinoids and their synthetic counterpoints for B2B sales and pharmaceutical potential InMed expects to have rare cannabinoids CBDV and THCV available for B2B sale to … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

Cepton, Inc. (NASDAQ: CPTN) Poised to Benefit as Non-Automotive Sector Becomes Increasingly Important for LiDAR Producers

Posted on April 6, 2022 by MissionIR

LiDARs have been one of key enablers for autonomous vehicle sector, but this unique technology offers use cases beyond automotive industry Consumer Electronics Show, one of the world’s most influential tech events, demonstrates that LiDAR is growing within non-automotive landscape, … Continue reading →

Posted in Cepton Inc. CPTN | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Q4 and Fiscal Year 2021 Results, Provides Business Update

Posted on April 5, 2022 by MissionIR

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced financial results for the fourth quarter and fiscal year ended Dec. 31, … Continue reading →

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Receives Key Approval for Pivotal Study of Berubicin

Posted on April 5, 2022 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has received key approval for a planned study. The approval came from Swissmedic, the … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Appoints Hull Xu as Chief Financial Officer

Posted on April 5, 2022 by MissionIR

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, today announced the appointment of Hull Xu, the company’s VP of finance and strategy, to the position of chief financial officer. Effective immediately, Xu succeeds Dr. … Continue reading →

Posted in Cepton Inc. CPTN | Leave a comment

MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Enters $100 Million Common Stock Purchase Agreement with B. Riley

Posted on April 5, 2022 by MissionIR

Knightscope, Inc. (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, yesterday announced that it entered into a $100 million common stock purchase agreement with B. Riley Principal Capital. Knightscope, which is celebrating its … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment